Supriya Lifescience News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Supriya Lifescience Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 4
Author: Deven Choksey

Keep track of all breaking news and updates on Supriya Lifescience from all sources in a single place.

Supriya Lifescience Ltd.

18 Aug 2026, 04:37PM

787.80

-1.73%

Earnings Call

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Earnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed.

pdf

Supriya Lifescience Ltd.

17 Aug 2026

787.80

-1.73%

Outlook

Accumulate: Supriya Lifescience Ltd.

Target

Deven Choksey

Supriya Lifescience’s growth remains backended to H2 FY27, with management reiterating its INR 1,000 crore revenue target and 33-35% EBITDA margin guidance as Q1 headwinds from solar policy charges and water shortages were temporary.

Supriya Lifescience .. has an average target of 841.00 from 1 broker.

Supriya Lifescience Ltd.

14 Aug 2026

787.80

-1.73%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30, 2026 is enclosed.

pdf

Supriya Lifescience Ltd.

14 Aug 2026

787.80

-1.73%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30, 2026.

pdf

Supriya Lifescience Ltd.

14 Aug 2026

787.80

-1.73%

to see Rapid results content

Supriya Lifescience Ltd.

13 Aug 2026

787.80

-1.73%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed herewith.

pdf

Supriya Lifescience Ltd.

13 Aug 2026

787.80

-1.73%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30,2026 is enclosed herewith.

pdf

Supriya Lifescience Ltd.

13 Aug 2026

787.80

-1.73%

Result

Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter Ended June 30, 2026.

BSE India

Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.

pdf

	Jun 2026	Mar 2026	Jun 2025	Change QoQ%	Change YoY%
Total Revenue Qtr	192.40	280.01	147.75	-31.3%	30.2%
Operating Profit Qtr	47.46	97.62	51.70	-51.4%	-8.2%
Net Profit Qtr	24.04	74.23	34.79	-67.6%	-30.9%
Earning Per Share Adjusted latest Qtr	2.99	9.22	4.32	-67.6%	-30.8%

* Standalone data

Detailed Results

Supriya Lifescience Ltd.

13 Aug 2026

787.80

-1.73%

Result

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday, August 13, 2026, inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30, 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m. Kindly take the above information on your records.

pdf

	Jun 2026	Mar 2026	Jun 2025	Change QoQ%	Change YoY%
Total Revenue Qtr	192.40	280.01	147.75	-31.3%	30.2%
Operating Profit Qtr	47.46	97.62	51.70	-51.4%	-8.2%
Net Profit Qtr	24.04	74.23	34.79	-67.6%	-30.9%
Earning Per Share Adjusted latest Qtr	2.99	9.22	4.32	-67.6%	-30.8%